Bulevirtide (Myrcludex B) is a NTCP inhibitor, a linear lipopeptide of 47 amino acids. Bulevirtide inhibits HBV and HDV entry into liver cells, blocks HBV infection in hepatocytes, and participates in HBV transcriptional suppression. Bulevirtide can be used in HDV infection and compensated cirrhosis research[1][2].
Molecular Weight:
5398.86
Purity:
99.70
CAS Number:
[2012558-47-1]
Formula:
C248H355N65O72
Target:
HBV
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted